Your browser doesn't support javascript.
loading
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
O'Donnell, Peter H; Arkenau, Hendrick Tobias; Sridhar, Srikala S; Ong, Michael; Drakaki, Alexandra; Spira, Alexander I; Zhang, Jingsong; Gordon, Michael S; Degboe, Arnold N; Gupta, Ashok K; Mukhopadhyay, Pralay; Huang, Wenmei; Abdullah, Shaad E; Angra, Natasha; Roskos, Lorin K; Guo, Xiang; Friedlander, Terence.
Affiliation
  • O'Donnell PH; Section of Hematology/Oncology, University of Chicago, Chicago, Illinois.
  • Arkenau HT; Sarah Cannon Research Institute, London, United Kingdom.
  • Sridhar SS; University College London Cancer Institute, London, United Kingdom.
  • Ong M; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Drakaki A; Ottawa Hospital, Ottawa, Ontario, Canada.
  • Spira AI; David Geffen School of Medicine, University of California, Los Angeles, California.
  • Zhang J; Virginia Cancer Specialists, Fairfax, Virginia.
  • Gordon MS; Moffitt Cancer Center, Tampa, Florida.
  • Degboe AN; HonorHealth Research Institute, Scottsdale, Arizona.
  • Gupta AK; AstraZeneca, Gaithersburg, Maryland.
  • Mukhopadhyay P; AstraZeneca, Gaithersburg, Maryland.
  • Huang W; AstraZeneca, Gaithersburg, Maryland.
  • Abdullah SE; AstraZeneca, Gaithersburg, Maryland.
  • Angra N; MedImmune, Gaithersburg, Maryland.
  • Roskos LK; MedImmune, Gaithersburg, Maryland.
  • Guo X; MedImmune, Gaithersburg, Maryland.
  • Friedlander T; MedImmune, Gaithersburg, Maryland.
Cancer ; 126(2): 432-443, 2020 01 15.
Article in En | MEDLINE | ID: mdl-31581306
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Biomarkers, Tumor / Antineoplastic Agents, Immunological / Inflammation / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Biomarkers, Tumor / Antineoplastic Agents, Immunological / Inflammation / Antibodies, Monoclonal Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article